Aquestive Therapeutics Strengthens Board of Directors with Appointments of Julie Krop, M.D., and Marco Taglietti, M.D., and Announces Resignation of Douglas K. Bratton from Board of Directors

NEXT STORY
AREV Appoints Dr. Roscoe Moore to Join the Advisory Board
PREV STORY
Apollomics, Inc. and Edison Oncology Announce Licensing Agreement for Novel Protein Tyrosine Kinase Inhibitor Targeting Solid Tumors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Precision Therapeutics Forms Scientific Advisory Board to Advance its Strategy in the Precision Medicine Sector

Marc Malandro PhD Named First Member of Scientific Advisory BoardMINNEAPOLIS , Sept. 06, 2018 ...

author_avatar
NASDAQ Market News

Centessa Pharmaceuticals Initiates Global Phase 3 ACTION Study of Lixivaptan in Autosomal Dominant Polycystic Kidney Disease, Reports Initial Positive Safety Data from ALERT Study, and Announces Notice of Allowance for Key Lixivaptan U.S. Patent Application

author_avatar
NASDAQ Market News

ALGAE DYNAMICS CORP ANNOUNCES C$400,000 RESEARCH GRANT FROM MITACS TO SUPPORT CANNABIS RESEARCH WITH UNIVERSITY OF WESTERN ONTARIO

TORONTO, Nov. 16, 2017 (GLOBE NEWSWIRE) -- ALGAE DYNAMICS CORP (OTC: ADYNF) (the "Company"), ...

author_avatar
NASDAQ Market News